covid19_science
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| covid19_science [2026/06/04 11:42] – [Major variants of concern or monitoring] gary1 | covid19_science [2026/06/04 11:42] (current) – [Major variants of concern or monitoring] gary1 | ||
|---|---|---|---|
| Line 35: | Line 35: | ||
| =====Major variants of concern or monitoring===== | =====Major variants of concern or monitoring===== | ||
| - | **BA 3.2 " | + | |
| * mid-2026 spreading across USA | * mid-2026 spreading across USA | ||
| *Nov 2025: Australia is seeing a mixture of the sub-variants NB.1.8.1, PQ.17, PE.1.4, RE.1.1, and increasingly commonly, LP.8.1. Aust. TGA has registered Pfizer’s LP.8.1 vaccine, designed specifically to target the spike protein of LP.8.1 | *Nov 2025: Australia is seeing a mixture of the sub-variants NB.1.8.1, PQ.17, PE.1.4, RE.1.1, and increasingly commonly, LP.8.1. Aust. TGA has registered Pfizer’s LP.8.1 vaccine, designed specifically to target the spike protein of LP.8.1 | ||
covid19_science.txt · Last modified: 2026/06/04 11:42 by gary1